Rebecca Slack Tidwell

Rebecca Slack Tidwell is a Senior Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on genitourinary cancers, specifically prostate and renal cell carcinoma, integrating oncology, pharmacology, and radiation oncology. Her recent work includes phase I/II trials of novel immunotherapy combinations, such as nivolumab, relatlimab, and ipilimumab in advanced renal cell carcinoma, and the PSMAxCD28 bispecific antibody nezastomig with cemiplimab in metastatic castration-resistant prostate cancer. She also investigates cardiometabolic health and adiposity’s impact on treatment outcomes in prostate cancer, with publications in the *Journal of Clinical Oncology*, *Nature Communications*, and *European Urology Focus*.